TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Fresenius Medical Care ( (FMS) ) is now available.
On November 17, 2025, Fresenius Medical Care successfully placed a €500 million bond maturing in November 2030 with a coupon of 3.250%, resulting in a yield of 3.334%. The proceeds are intended for general corporate purposes, including refinancing existing financial liabilities. This strategic financial move under Fresenius Medical Care’s Debt Issuance Program is expected to enhance the company’s financial flexibility and support its ongoing operations, further solidifying its position in the renal care industry.
The most recent analyst rating on (FMS) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Fresenius Medical Care stock, see the FMS Stock Forecast page.
Spark’s Take on FMS Stock
According to Spark, TipRanks’ AI Analyst, FMS is a Neutral.
Fresenius Medical Care’s overall score is driven by strong earnings call performance and fair valuation, offset by technical analysis indicating bearish trends and financial performance challenges. The company’s strategic initiatives and share buyback program are positive, but operational and market challenges remain.
To see Spark’s full report on FMS stock, click here.
More about Fresenius Medical Care
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, serving around 4.2 million patients globally who regularly undergo dialysis treatment. The company operates a network of 3,628 dialysis clinics, providing treatments for approximately 294,000 patients worldwide. Additionally, Fresenius Medical Care is a leading provider of dialysis products, such as dialysis machines and dialyzers, and is listed on the Frankfurt Stock Exchange and the New York Stock Exchange.
Average Trading Volume: 377,545
Technical Sentiment Signal: Sell
Current Market Cap: $13.64B
For a thorough assessment of FMS stock, go to TipRanks’ Stock Analysis page.